Recombinant Human Aquaporin-11 (AQP11)

What are the expression patterns of AQP11 in mammalian tissues?

AQP11 demonstrates tissue-specific expression patterns that have been characterized in multiple studies. In brain tissue, AQP11 localizes primarily to capillary endothelium in cerebral white matter, with expression partially overlapping with glucose transporter 1 (GLUT1) . This suggests potential involvement in blood-brain barrier (BBB) function. Expression patterns change during development, with significant presence in leptomeninges early after birth (P1) and stronger expression in capillary endothelial cells as the brain matures (P28) .

In kidney tissue, AQP11 is highly expressed in proximal tubular epithelial cells, particularly in the S1 proximal tubule segment where major renal glucose flux occurs . Recent transcriptomic analyses have also identified AQP11 in human cortex and hippocampus, with expression levels correlating with age and Alzheimer's disease status .

Cell-specific expression has been observed, with robust expression in astrocytes (1321N1 cells) after inflammatory stimulation, but limited expression in neuronal cells (SHSY5Y) .

What experimental methods are recommended for detecting AQP11 protein expression?

Multiple complementary techniques are recommended for reliable detection of AQP11:

Western Blotting:

• Sample preparation: Use renal cortex tissue homogenates (3 μg per lane) resolved on denaturing SDS-PAGE under reducing conditions with β-mercaptoethanol using 12% Bis-Tris gels

• Transfer conditions: Transfer to PVDF membranes using Tris-glycine buffer at 20V overnight at room temperature

• Antibody selection: Primary rabbit polyclonal antibody to the COOH terminus of AQP11 (1:1,000 dilution; commercial sources like Alpha Diagnostic)

• Controls: Include antibody specificity validation by preincubation with blocking peptide containing AQP11 amino acid sequence

Immunocytochemistry/Immunofluorescence:

• For subcellular localization, double-immunostaining with membrane markers (Na⁺-K⁺-ATPase) or organelle markers (ER Cytopainter) is effective

• Quantification using imaging systems like HALO and confocal Z-stack analysis with IMARIS provides detailed localization information

RT-PCR for transcript detection:

• RNA isolation: Use RNeasy Lipid Tissue Mini Kit for brain samples, RNeasy Mini Kit for kidney samples

• Primer selection: Design primers from different exons to suppress genomic amplification

• Recommended primers: sense 5′-CTGCTGGCTGCACTCATC-3′ and antisense 5′-TTGAGAAATACAGGCTAC-3′

• Include GAPDH amplification as internal control

What are the key characteristics of recombinant human AQP11 protein?

Recombinant human AQP11 protein has been successfully produced with the following specifications:

This characterization provides researchers with critical information for experimental design using recombinant AQP11 .

How does AQP11 expression change in response to cellular stress?

AQP11 expression demonstrates dynamic regulation in response to cellular stressors. When exposed to lipopolysaccharide (LPS, 100 ng/ml for 24h), 1321N1 astrocytes show a remarkable 10-fold increase in AQP11 protein expression compared to non-stressed controls . This response appears to be cell-type specific, as differentiated SHSY5Y neurons did not show appreciable changes in AQP11 protein levels under the same conditions, despite increases in AQP11 transcript .

Stress-induced changes in AQP11 expression involve both transcriptional and translational regulation. The differential response between cell types suggests potential post-transcriptional regulatory mechanisms affecting AQP11 protein synthesis, which may require longer than 24 hours in neuronal cells .

This stress-responsive regulation appears to be part of a protective mechanism, as siRNA knockdown of AQP11 removed the protective effect of LPS pretreatment, rendering cells more vulnerable to oxidative stress from H₂O₂ exposure .

What methodological approaches are effective for studying AQP11 quaternary structure and oligomerization?

Analyzing AQP11 quaternary structure requires specialized techniques to preserve native protein conformation:

Native Gel Electrophoresis:

• Sample preparation is critical for maintaining oligomeric structure

• For comparing wild-type versus mutant AQP11, careful preparation of tissue homogenates under non-reducing, non-denaturing conditions is essential

• Avoid heat denaturation that disrupts quaternary structure

Site-Directed Mutagenesis:

• For studying structure-function relationships, site-directed mutagenesis can be employed to generate specific mutations (e.g., Cys227Ser mutation)

• Construct plasmids with wild-type and mutant AQP11 for transfection and comparative analysis

• The Myc-tagged AQP11 construct can be made by in-frame subcloning of human AQP11 cDNA into expression vectors like pCMV-Myc

Research has shown that the Cys227Ser mutation interferes with maintenance of AQP11 oligomeric structure, highlighting the importance of this conserved residue for proper protein assembly and function . This methodological approach has provided insights into how structural alterations can lead to functional consequences, including ER stress and cellular injury.

How can researchers effectively implement AQP11 knockdown studies to investigate functional roles?

Knockdown studies provide critical insights into AQP11 function. Based on successful methodologies:

siRNA Knockdown Protocol:

• Optimize transfection conditions using multiple siRNA kits (e.g., Ambion S49052 & S49053 for AQP11)

• Include appropriate scrambled negative controls (e.g., Ambion 4390843 & 4390846)

• Determine optimal silencing duration through time course experiments (72 hours post-transfection has shown maximal knockdown for AQP11)

• Replace transfection media with fresh medium after 48 hours

• Validate knockdown efficiency at both transcript (qPCR) and protein levels (immunocytochemistry)

• Assess functional outcomes using relevant assays (e.g., MDA assay for lipid peroxidation)

Critical Considerations:

• Cell-type specific responses must be accounted for in experimental design

• Knockdown may have different effects in different cell types due to varying baseline expression and functional roles

• Complete validation of knockdown requires both transcript and protein level measurements

• Include appropriate controls (scrambled siRNA, untreated cells) in all experiments

This approach has revealed important insights, such as the protective role of AQP11 against oxidative stress, where knockdown rendered astrocytes more vulnerable to lipid peroxidation following H₂O₂ exposure .

What is the relationship between AQP11 and other aquaporins in the central nervous system?

AQP11 functions in a complex network with other aquaporins in the central nervous system:

Functional Coupling with AQP4:

• AQP11 may function in series with AQP4 at the blood-brain barrier

• Comparative expression analysis in AQP11-deficient mice shows that mRNA expression levels for AQP4 and GFAP decreased by approximately 50% in the brain compared to wild-type mice

• This suggests regulatory interactions or compensatory mechanisms between these aquaporins

Expression Pattern Distinctions:

• While AQP4 is primarily expressed in astrocyte endfeet surrounding brain capillary endothelial cells, AQP11 is expressed at the capillary endothelium itself

• AQP1 expression appears unaffected in AQP11-deficient mice, indicating specificity in the AQP11-AQP4 relationship

Methodological Approach for Comparative Analysis:

• RT-PCR for quantitative comparison of expression levels between wild-type and knockout models

• Double immunofluorescent staining with markers for different cell types

• Functional assays to assess compensatory mechanisms

This relationship suggests that AQP11 and AQP4 may participate in coordinated water transport across the BBB, with implications for understanding brain fluid homeostasis in both normal and pathological conditions.

How does the subcellular localization of AQP11 influence its functional roles?

AQP11 exhibits distinct subcellular localization patterns that inform its functional roles:

Dual Localization Pattern:

• Plasma Membrane: Double-immunostaining with Na⁺-K⁺-ATPase confirms AQP11 localization in the plasma membrane of astrocytes, particularly after LPS stimulation

• Endoplasmic Reticulum: Co-staining with ER markers (Cytopainter) demonstrates significant ER localization, which increases after LPS stress

Functional Implications:

• ER Localization: Associated with maintenance of ER homeostasis, where disruption leads to ER stress and unfolded protein response

• Plasma Membrane Localization: May be involved in peroxiporin function, allowing transport of hydrogen peroxide and potentially other molecules across membranes

Cell-Type Specificity:

• Robust expression in both membrane and ER compartments in astrocytes

• Limited expression in neuronal cells

Stress-Responsive Trafficking:

This dual localization pattern suggests AQP11 may serve different functions depending on its subcellular location: maintenance of ER homeostasis when localized to the ER, and peroxiporin function when present at the plasma membrane. Understanding this compartment-specific functionality requires careful subcellular fractionation techniques and co-localization studies.